Vir Biotechnology earnings were -$577.6M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest VIR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$121.0M, up 15.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VIR reported annual earnings of -$522.0M, with -15.1% growth. The next VIR earnings date is Jul 30, 2025.
What were Vir Biotechnology's earnings last quarter?
On VIR's earnings call on Invalid Date, Vir Biotechnology (NASDAQ: VIR) reported Q1 2025 earnings per share (EPS) of -$0.88, up 83.33% year over year. Total VIR earnings for the quarter were -$120.97 million. In the same quarter last year, Vir Biotechnology's earnings per share (EPS) was -$0.48.
The next VIR earnings date is Invalid Date. Add VIR to your watchlist to be reminded of Vir Biotechnology's next earnings date.
What was VIR's earnings growth in the past year?
As of Vir Biotechnology's earnings date in Invalid Date, Vir Biotechnology's earnings has grown year over year. VIR earnings in the past year totalled -$577.65 million.
Is Vir Biotechnology profitable or losing money?
As of the last Vir Biotechnology earnings report, Vir Biotechnology is currently losing money. Vir Biotechnology's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$577.65 million, a 7.08% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.